Who founded Swing Therapeutics?

Swing Therapeutics was founded by Michael Rosenbluth in 2019.

Who are Swing Therapeutics's investors?

Swing Therapeutics's investors include Kicker Ventures, JAZZ Human Performance, JAZZ Venture Partners, Metrodora Ventures.

How much funding has Swing Therapeutics raised?

Swing Therapeutics has disclosed $34.2M raised across 4 rounds.

Where is Swing Therapeutics headquartered?

Swing Therapeutics is headquartered in San Francisco, US.

Swing Therapeutics

San Francisco, US · Founded 2019 · Delaware corporation · 4 known investors

Biotech Healthtech

Founders & leadership

Swing Therapeutics was founded in 2019 by Michael Rosenbluth.

Michael RosenbluthFounder

Board

Andrew Firlik in 𝕏Board directorManaging Partner at JAZZ Venture Partners

Zack Lynch in 𝕏Board directorManaging Partner at JAZZ Venture Partners

Corey McCannBoard director

Investors · 4

Kicker VenturesMenlo Park · $100K – $1Mvia Masashi Kiyomine · inferred

JAZZ Human PerformancereportedSan Francisco

JAZZ Venture Partnersreported · 2 sourcesSan Francisco · $100K – $20Mvia Andrew Firlik · board

Metrodora VenturesreportedNew York

Reported raises · per SEC filings

Form D private placements

$34.2M disclosed across 4 rounds · 2019–2025

▶$3.3MraisedSep 2025 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Michael RosenbluthExecutive Officer, Director
Corey McCannDirector
Andrew FirlikDirector
Zack LynchDirector

Offering amount: $3.3M
Amount sold: $3.3M
First sale: Aug 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11.4MraisedAug 2025 · 14 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Corey McCannDirector
Andrew FirlikDirector
Michael RosenbluthExecutive Officer, Director
Zack LynchDirector

Offering amount: $14.6M
Amount sold: $11.4M
First sale: May 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$10.3MraisedJul 2022 · 11 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Michael RosenbluthExecutive Officer, Director
Andrew FirlikDirector
Zack LynchDirector

Offering amount: $12.5M
Amount sold: $10.3M
First sale: Jan 2022
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$9.2MraisedJul 2022 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Zack LynchDirector
Michael RosenbluthExecutive Officer, Director
Andrew FirlikDirector

Offering amount: $9.3M
Amount sold: $9.2M
First sale: Aug 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Swing Therapeutics raises $11 million, adds former Pear CEO to board | STATstatnews.com · Sep 2025

Swing Therapeutics Closes $10.3M Series A Funding Roundswingtherapeutics.com · Jun 2022

Swing Therapeutics Raises $9M in Seed Fundingfinsmes.com · Aug 2021

Frequently asked questions

Who founded Swing Therapeutics?: Swing Therapeutics was founded by Michael Rosenbluth in 2019.
Who are Swing Therapeutics's investors?: Swing Therapeutics's investors include Kicker Ventures, JAZZ Human Performance, JAZZ Venture Partners, Metrodora Ventures.
How much funding has Swing Therapeutics raised?: Swing Therapeutics has disclosed $34.2M raised across 4 rounds.
Where is Swing Therapeutics headquartered?: Swing Therapeutics is headquartered in San Francisco, US.